Choosing The Right Hemodynamic Monitor in 2021
What Parameters to Consider When Choosing a Hemodynamic Monitoring System
A hemodynamic monitoring system is crucial in the assessment of cardiac performance and hemodynamic parameters, especially in critically ill patients. It is now proven that measuring cardiac output and its underlying causes is vital in helping the clinician to interpret patient condition and finally choose the right treatment plan. However, there is no dearth of these monitors of varying prices in the market, and choosing the right one can become a little difficult.
An ideal hemodynamic system should provide continuous, real-time values while being easy-to-handle, reliable, and finds broad implantation, especially in pediatrics and critical care. But most importantly, it should be economical without compromising on its efficacy and sensitivity.
Let us first review one of the popular hemodynamic monitors available in the market – Hemosphere Advanced Platform. It is a unique all-in-one platform integrating the best of all worlds – cold bolus thermodilution, Vigilance technology, and different Pulse Contour Methods (PCM) algorithms.
It can be implemented using different dedicated disposables, the Swan-Ganz Pulmonary Artery Catheter, FloTrac sensor, and Acumen IQ sensor. Swan-Ganz PAC, deemed as the Gold standard, despite being highly invasive, risky, and cumbersome, performs accurate hemodynamic profiling of both, adult and pediatric patients (>5kg), after external calibration by cold bolus thermodilution.
Using FloTrac (BP transducer) in conjunction with any arterial catheter is a minimally invasive system based on an uncalibrated PCM algorithm deriving cardiac output from a pre-estimated patient database continuously measures hemodynamic parameters every 20s. However, the algorithm exhibits proven limitations endangering the accuracy and reliability of the system.
The third new dedicated transducer, the Acumen IQ sensor, unlocks the “Acumen Hypotension Index” software on the Hemosphere monitor, which has the exclusive ability to predict the likelihood of a Hypotensive event (Hypotensive Predictive Index, HPI) of a patient while displaying the standard hemodynamic parameters simultaneously at the rate of 20s.
Despite its limitation of displaying non-real-time and imperfect values under certain conditions, this open platform holds future scope of including potential technologies.
Now, let us see how the most advanced system, MostCare Up, offered by Vygon, is spearheading the hemodynamic monitoring market.
Vygon’s MostCare Up is the only minimally invasive hemodynamic monitor that can follow in real-time, every beat and even the slightest hemodynamic variations in the patient, powered by the patented algorithm of PRAM (Pressure Recording Analytical Method) that evaluates the cardiac output, without any prior calibration or anthropometric database, with maximum accuracy at a sampling rate of 1000Hz that expedites the detection of the dicrotic notch at every beat.
MostCare Up’s supremacy is attributed to its consistent triumphs over existing limitations of other monitors with its exclusive features; it finds strong validation and wide applicability in critical care patients with IABP, Arrhythmia, septic, and pediatric patients of all weight and ages and is implementable on any peripheral or femoral artery using no dedicated and/or change of disposable. Besides high flexibility, transferability, and adaptability, it provides ease of use to the operator and displays a string of exclusive variables barring the standard ones. It is a preferred option as it is adaptable to the current system with no additional accessory and has a provision to even maintain arterial BP on the existing monitor.
Although the Endless version of MostCare Up requires no consumables, the On-Demand version requires dedicated Timecards for stipulated durations (24hrs, 1mth, 6mth) or one-time Patient cards (1, 10, 50 nos) for activation of the system, thus proving to be highly economical when used as per requirement.
As Vygon firmly believes in equipping medical professionals with simple yet quality and reliable medical products to facilitate premium healthcare to all, we hoped to give an objective insight into two of the most in-demand hemodynamic monitors to help you decide if it is worth your investment.
Vygon, established in France in 1962, is one of the pioneers and leading global players in the medical devices and technology market, recognized for the most innovative and reliable inventions; aims at empowering all with the finest technology to uptake enhanced clinical decisions in their practice and reach the pinnacle of accuracy meeting simplicity.